Teladoc rises on expanding obesity drugs program

Teladoc Health

07/03/2024 15:22

** Shares of Shares of virtual healthcare provider Teladoc
Health Inc  TDOC.N  rise 2.4% to $14.94 
    ** Co says it is expanding its obesity drugs program to help
employers and health insurers manage rising demand for new
weight-loss drugs
    ** New features will help sponsors and pharmacy benefit
managers in reducing costs of obesity related medical expenses-
TDOC  
     ** TDOC last year expanded its telehealth services to
include prescribing obesity drugs such as Novo Nordisk's
 NOVOb.CO  Wegovy
    ** Separately, Cigna  CI.N  on Thursday launched a program
aimed at limiting the amounts health insurance providers and
employers spend on new weight-loss drugs  
    ** Including session moves, stock has fallen 41.2% in the
last 12 months  

 (Reporting by Sneha S K in Bengaluru)
 ((Sneha.SK@thomsonreuters.com;))